Research output per year
Research output per year
Personal profile
Expertises
Immune monitoring; T-cell therapy; Dendritic cell vaccination
Main research areas
Immune monitoring following cell therapy using dendritic cell vaccination or T-cell therapy in metastatic melanoma patients.
Current research
Immune monitoring following T-cell therapy.
Potential conflicts of interest
None
Fingerprint
Dive into the research topics where Troels Holz Borch is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma
Rohaan, M. W., Borch, T. H., van den Berg, J. H., Met, Ö., Kessels, R., Geukes Foppen, M. H., Stoltenborg Granhøj, J., Nuijen, B., Nijenhuis, C., Jedema, I., van Zon, M., Scheij, S., Beijnen, J. H., Hansen, M., Voermans, C., Noringriis, I. M., Monberg, T. J., Holmstroem, R. B., Wever, L. D. V., van Dijk, M., & 37 others, 8 Dec 2022, In: The New England journal of medicine. 387, 23, p. 2113-2125 13 p.Research output: Contribution to journal › Journal article › Research › peer-review
-
Adoptive cell therapy with tumor-infiltrating lymphocytes supported by checkpoint inhibition across multiple solid cancer types
Kverneland, A. H., Chamberlain, C. A., Borch, T. H., Nielsen, M., Mørk, S. K., Kjeldsen, J. W., Lorentzen, C. L., Jørgensen, L. P., Riis, L. B., Yde, C. W., Met, Ö., Donia, M. & Marie Svane, I., 4 Oct 2021, In: Journal for ImmunoTherapy of Cancer. 9, 10, e003499.Research output: Contribution to journal › Journal article › Research › peer-review
15 Citations (Scopus) -
Bone marrow toxicity and immune reconstitution in melanoma and non-melanoma solid cancer patients after non-myeloablative conditioning with chemotherapy and checkpoint inhibition
Kverneland, A. H., Borch, T. H., Granhøj, J., Sengeløv, H., Donia, M. & Svane, I. M., Aug 2021, In: Cytotherapy. 23, 8, p. 724-729 6 p.Research output: Contribution to journal › Journal article › Research › peer-review
3 Citations (Scopus) -
Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma
Borch, T. H., Harbst, K., Rana, A. H., Andersen, R., Martinenaite, E., Kongsted, P., Pedersen, M., Nielsen, M., Kjeldsen, J. W., Kverneland, A. H., Lauss, M., Hölmich, L. R., Hendel, H., Met, Ö., Jönsson, G., Donia, M. & Marie Svane, I., Jul 2021, In: Journal for ImmunoTherapy of Cancer. 9, 7, e002703.Research output: Contribution to journal › Journal article › Research › peer-review
7 Citations (Scopus) -
Metastatic melanoma presenting with subacute sensory neuronopathy
Holm-Yildiz, S., Crone, C., Borch, T. H. & Jeppesen, T. D., Aug 2021, In: Muscle & Nerve. 64, 2, p. E5-E6Research output: Contribution to journal › Letter › peer-review